Sanara MedTech, a Fort Worth, TX-based medical technology company, entered into a $55 million non-dilutive term loan agreement with CRG Servicing, an affiliate of CRG, a healthcare focused investment fund, to support growth initiatives in 2024 and 2025.
NavaDerm Partners completed a financing with CRG. Through the transaction, NavaDerm will initially access $20 million of debt, with the option to draw a further $10 million at its discretion and upon achieving certain milestones in 2021 and 2022.
EyePoint Pharmaceuticals announced an amendment to its existing debt facility with healthcare investment firm CRG Servicing. The amendment reduces the net product revenue covenant from $80 million to $45 million.
Correvio Pharma amended its existing agreement with CRG Servicing to provide for an increase in capital. Under the terms of the amendment, Correvio is now eligible to receive up to an additional $10 million.
NanoString Technologies entered into a new $100 million term loan facility with the CR Group, a health care focused investment firm.
Affiliates of investment firm CRG amended the credit facility for Omeros, a biopharmaceutical company focused on small-molecule and protein therapeutics.
Dynavax Technologies closed on a $175 million non-dilutive term loan agreement with CRG. a healthcare focused investment firm.
Synergy Pharmaceuticals closed $300 million in senior secured loans from CRG, a healthcare-focused investment firm.
Strongbridge Biopharma entered into a $50 million senior credit facility with CRG. a healthcare-focused investment firm, to retire its existing debt facility and provide additional capital for the company.
Viveve Medical entered into a $30 million senior credit facility with affiliates of CRG to retire its existing credit facility and provide additional capital for the company.